Published in Lancet on November 14, 1998
Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. PLoS One (2013) 0.78
Dipeptidyl peptidase 10 (DPP10(789)): a voltage gated potassium channel associated protein is abnormally expressed in Alzheimer's and other neurodegenerative diseases. Biomed Res Int (2014) 0.78
Abnormal potassium-channel function in platelets in Alzheimer's disease. Lancet (1999) 0.77
Phobic memory and somatic vulnerabilities in anorexia nervosa: a necessary unity? Ann Gen Psychiatry (2005) 0.75
Abnormal potassium-channel function in platelets in Alzheimer's disease. Lancet (1999) 0.75
Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 16.12
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol (1996) 4.50
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol (1998) 4.48
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94
The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta (1984) 3.58
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem (1967) 3.03
Subclinical slipped capital femoral epiphysis. Relationship to osteoarthrosis of the hip. J Bone Joint Surg Am (1997) 2.97
Ontogeny of orientation flight in the honeybee revealed by harmonic radar. Nature (2000) 2.86
A simple method for the isolation of adrenal chromaffin granules on a large scale. Biochem J (1967) 2.84
Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem J (1967) 2.82
Techniques of endopyelotomy. Br J Urol (1998) 2.68
Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J (1973) 2.53
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br J Clin Pharmacol (1975) 2.49
Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet (2003) 2.47
The blind-loop syndrome. Monogr Surg Sci (1967) 2.43
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Lancet (1979) 2.42
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol (2001) 2.33
Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (1967) 2.29
Medication errors, worse than a crime. Lancet (2000) 2.24
A prescription for better prescribing. Br J Clin Pharmacol (2006) 2.24
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol (1992) 2.10
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication. Br Med J (1969) 2.08
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience (1984) 2.05
Integrated healthcare: a way forward for the next five years? A discussion document from the Prince of Wales's Initiative on Integrated Medicine. J Altern Complement Med (1998) 2.05
Mechanism of the antidepressant action of electroconvulsive therapy. Lancet (1978) 2.03
Secretion from the adrenal medulla: biochemical evidence for exocytosis. Br J Pharmacol Chemother (1967) 2.03
Mediators of long-term memory performance across the life span. Psychol Aging (1996) 2.01
The flight paths of honeybees recruited by the waggle dance. Nature (2005) 2.01
Exhaled nitric oxide measurements: clinical application and interpretation. Thorax (2006) 2.01
Civilian vascular injuries: a critical appraisal of three decades of management. Ann Surg (1970) 1.97
IscA, an alternate scaffold for Fe-S cluster biosynthesis. Biochemistry (2001) 1.93
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor. Br J Pharmacol (1971) 1.90
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
Rare diseases and orphan drugs. Br J Clin Pharmacol (2006) 1.83
Misuse of temazepam. BMJ (1991) 1.82
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain (2002) 1.81
Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature (1976) 1.77
Endopyelotomy for horseshoe and ectopic kidneys. J Urol (1998) 1.76
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
An aerial netting study of insects migrating at high altitude over England. Bull Entomol Res (2004) 1.75
Balanced prescribing. Br J Clin Pharmacol (2006) 1.74
Ultrastructural studies on the adrenal medulla of golden hamster: origin and fate of secretory granules. Z Zellforsch Mikrosk Anat (1972) 1.74
Congenital constriction band syndrome causing ulnar nerve palsy: early diagnosis and surgical release with long-term follow-up. J Hand Surg Am (2001) 1.73
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Open surgical exploration after failed endopyelotomy: a 12-year perspective. J Urol (1997) 1.68
Percutaneous transperitoneal approach to a pelvic kidney for endourological removal of staghorn calculus. J Urol (1985) 1.67
Purification and characterization of bovine brain type I phosphatidylinositol kinase. Eur J Biochem (1990) 1.67
Gangrene and Fournier's gangrene. Urol Clin North Am (1992) 1.63
Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience (1984) 1.60
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58
Measurement of specific [3H]-ouabain binding to different types of human leucocytes. Br J Clin Pharmacol (1984) 1.56
Diseases of meaning, manifestations of health, and metaphor. J Altern Complement Med (1999) 1.56
Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res (1996) 1.54
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J Neurosci (1984) 1.51
Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br J Pharmacol (1976) 1.48
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response. Br J Clin Pharmacol (1977) 1.44
Rational prescribing, appropriate prescribing. Br J Clin Pharmacol (2004) 1.43
Prescribing statins. Br J Clin Pharmacol (2005) 1.42
A new type of specific interneuron in the monkey hippocampus forming synapses exclusively with the axon initial segments of pyramidal cells. Brain Res (1983) 1.42
Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse (1991) 1.42
Transmembrane oxalate exchange: its relationship to idiopathic calcium oxalate nephrolithiasis. J Urol (1992) 1.42
Membranes of the adrenal medulla. Behaviour of insoluble proteins of chromaffin granules on gel electrophoresis. Biochem J (1970) 1.41
The localization of lysosomal enzymes in chromaffin tissue. J Physiol (1966) 1.40
Approaches to the superior calix: renal displacement technique and review of options. J Urol (1989) 1.40
Fibrous coagulum: a new cause of retained fragments following extracorporeal shock wave lithotripsy. J Urol (1995) 1.40
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Modular organization and identification of a mononuclear iron-binding site within the NifU protein. J Biol Inorg Chem (2000) 1.40
Lipids of the adrenal medulla. Lysolecithin, a characteristic constituent of chromaffin granules. Biochem J (1967) 1.39
Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology (2008) 1.39
Alternative medicine, education and standards of publication and research. J Altern Complement Med (1999) 1.39
Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiatry (1970) 1.39
Iatrogenic chest pain: a case of 5-fluorouracil cardiotoxicity. QJM (1996) 1.39
In defence of polypharmacy. Br J Clin Pharmacol (2004) 1.38
Proceedings: An isolated perfused rat brain--some histological and metabolic features. Clin Sci Mol Med (1974) 1.38
The Glidewire technique for overcoming urethral obstruction. J Urol (1996) 1.38
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet (1994) 1.38
Normal hearing thresholds for clicks. J Acoust Soc Am (1982) 1.37
Antiperistaltic segments after massive intestinal resections. Lancet (1966) 1.36
Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Neuropharmacology (1976) 1.35
5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol (1989) 1.35
Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology (Berl) (1977) 1.35
Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34
Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure. J Comp Neurol (1981) 1.34
Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes. Clin Sci (Lond) (1985) 1.34